Search | Buyers.sg

added article Others

2025-11-17 10:03:59 -

How Is Ultomiris Capturing Share in the Global Complement Inhibitor Drug Market?

Ultomiris Drug Market Overview 2025–2033: Size, Growth Drivers, Key Segments, and Competitive Landscape The Ultomiris drug market is experiencing one of the fastest growth trajectories in the rare disease and biologics sector. Ultomiris (ravulizumab-cwvz), developed and marketed by AstraZeneca (through its subsidiary Alexion Pharmaceuticals, acquired in 2021), has...

0 Comments 0 Shares 44 Views 0 Reviews